Last updated on June 2018

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Brief description of study

The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development of the fetus/infant at birth and for the first 2 years will also be followed.

Clinical Study Identifier: NCT02556775

Contact Investigators or Research Sites near you

Start Over

Fakultni nemocnice Kralovske Vinohrady
Praha 10, Czechia

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.